Spinal Muscular Atrophy Foundation Announces Collaboration with PTC Therapeutics
News Jun 08, 2006
The collaboration is designed to leverage PTC’s proprietary Gene Expression Modulation by Small molecules (GEMS) technology to identify and develop small molecule therapeutics for use in the treatment or prevention of spinal muscular atrophy (SMA).
Under the terms of the agreement, the SMA Foundation will provide up to $1.6 million in funding to PTC based upon completion of certain milestones.
"PTC has demonstrated a strong commitment to SMA and other pediatric orphan diseases," said Loren Eng, President of the SMA Foundation.
"We believe PTC’s scientific assets and proven accomplishments make them an ideal partner in our efforts to identify treatments for SMA."
PTC’s GEMS technology exploits the regulatory mechanisms found in the untranslated regions of messenger RNA for the identification of small-molecule drugs that can treat diseases by selectively increasing or decreasing the expression of key proteins by modulating post-transcriptional mechanisms.
Another SMA Foundation research project will explore the application of PTC’s nonsense suppression compounds and technology to SMA.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE